000			02345 a2200637 4500
005			20250513225929.0
264		0	_c20010322
008			200103s 0 0 eng d
022			_a0923-7534
024	7		_a10.1023/a:1026579400806 _2doi
040			_aNLM _beng _cNLM
100	1		_aMiller, W H
245	0	0	_aA phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cNov 2000
300			_a1387-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAlitretinoin
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aCarcinoma, Renal Cell _xdrug therapy
650	0	4	_aChemical and Drug Induced Liver Injury _xetiology
650	0	4	_aCombined Modality Therapy
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Synergism
650	0	4	_aFatigue _xchemically induced
650	0	4	_aFemale
650	0	4	_aFever _xchemically induced
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xadministration & dosage
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aKidney Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNephrectomy
650	0	4	_aPain _xchemically induced
650	0	4	_aRecombinant Proteins
650	0	4	_aRemission Induction
650	0	4	_aTreatment Failure
650	0	4	_aTretinoin _xadministration & dosage
700	1		_aReyno, L M
700	1		_aLoewen, G R
700	1		_aHuan, S
700	1		_aWinquist, E
700	1		_aMoore, M
700	1		_aCato, A
700	1		_aJaunakais, D
700	1		_aTruglia, J A
700	1		_aMatthews, S
700	1		_aDancey, J
700	1		_aEisenhauer, E
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 11 _gno. 11 _gp. 1387-9
856	4	0	_uhttps://doi.org/10.1023/a:1026579400806 _zAvailable from publisher's website
999			_c11082503 _d11082503